BRAF and neoplasm: The majority of reported cases were published before the advent of molecular biology, reclassified in a wide spectrum of CNS WHO tumour types without a distinct methylation class [28] or more interestingly were midline-located with a co-occurring BRAF and H3-K27M mutations [11, 21–23, 26, 29, 30, 44].